CTRI/2019/09/021297
Not yet recruiting
未知
Comparative evaluation of host immune response and cytokine signature pertaining toTh1 and Th2 immune arms in serum and tissue among patients of acute localized versus chronic disseminated dermatophytosis, hospital based observational study. - None
ConditionsHealth Condition 1: B356- Tinea cruris
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: B356- Tinea cruris
- Sponsor
- Indian Association of Dermatologists Venereologists and Leprologists
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients of either sex age between 18 to 60 years.
- •2\.Skin condition clinically diagnosed as dermatophytosis involving non glabrous skin (exluding tinea unguim and tinea capitis)
- •3\.Presence of fungus in scrapping taken from lesion by in KOH preparation.
- •4\.Women of child bearing age must have a negative urine pregnancy test.
- •5\. Patient willing to give written informed consent.
Exclusion Criteria
- •1\.Patient less than 18 years age and more than 60 years.(DOB, govt approved document in case of doubt)
- •2\.Preexisting Cardiovascular, pulmonary, hepatic, renal, hematological, gastrointestinal, endocrine, immunologic, musculoskeletal, neurological or psychiatric disease.(History and medical record)
- •3\.Major surgical or medical illness in last 4 weeks before screening.(History and medical record)
- •4\.Any concomitant medication for purpose other than dermatophytosis management at presentation or within last 4 weeks before screening. (History and medical record).
- •5\.Patient with concommitent asthma, atopic dermatitis allergic rhinitis. Patient with past history of same documented on medical records will also be exluded from study.
- •6\.Patients on corticosteroid or have taken same during last 4 weeks.
- •7\.Patinets who are on at present or treated during last 6 months with any biologic medication.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
The study to compare the immune response between intradermal and intramuscular injection of botulinum toxin AHealthy human volunteersEnzyme-Linked Immunosorbent Assay, Botulinum Toxins, Immunoglobulins, AntibodiesTCTR20211204002Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand100
Active, not recruiting
Not Applicable
A Clinical trial to analysis of immune profile following neoadjuvant chemotherapy in colorectal liver metastases patientsNeoplasmsKCT0003474Asan Medical Center20
Recruiting
Not Applicable
Study on host immune response during treatment of patients with pulmonary nontuberculous mycobacterial diseasepulmonary nontuberculous mycobacterial diseaseJPRN-UMIN000049658Department of Respiratory Medicine, University of Tsukuba100
Completed
Phase 4
Comparition of immunity and reaction of bOPV vaccine and tOPV vaccine in routine immunization schedule, with or without IPV vaccine administration at DTP3 vaccine contact: A controlled trialCTRI/2013/06/003722World health Organization900
Completed
Not Applicable
Comparative evaluation of immunogenicity and reactogenicity of monovalent type 2 and 3 oral poliovirus vaccines (mOPV 2 and mOPV3) versus trivalent oral poliovirus vaccine (tOPV), and bivalent oral poliovirus vaccine (bOPV) versus monovalent types 1 and 3 oral poliovirus vaccines, respectively: a randomised double-blind trialISRCTN64725429Panacea Biotec Limited (India)900